| Pharmaceutical active ingredients: |
| Lithium Carbonate |
| Available forms, composition and doses of Eskalith CR: |
| Tablets, Extended Release; Oral; Lithium Carbonate 450 mg |
| Eskalith CR medical category: |
| Human:AntidepressantsAntimanic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05AN - LithiumN05AN01 - Lithium |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Related documents and information about Eskalith CR: |
| Eskalith prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Eskacillin V | Penicillin V | Unidentified Pharmaceutical Company |
| Eskadiazine | Sulfadiazine | Unidentified Pharmaceutical Company |
| Eskaflam | Nimesulide | GlaxoSmithKline |
| Eskalin | Virginiamycin | Unidentified Pharmaceutical Company |
| Eskalith | Lithium Carbonate | GlaxoSmithKline |
| Eskamel | Resorcinol; Sulfur precipitated | GlaxoSmithKline; Dermatech Laboratories; Goldshield Pharmaceuticals; Group Laboratories |
| Eskapar | Nifuroxazide | Armstrong Laboratorios de Mexico |
| Eskapar Compuesto | Metronidazole; Nifuroxazide | Armstrong Laboratorios de Mexico |
| Eskapen | Vitamin B1 | Unidentified Pharmaceutical Company |
| Eskaphen | Vitamin B1 | Unidentified Pharmaceutical Company |